Your browser doesn't support javascript.
loading
Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.
Gentinetta, Thomas; Belcher, John D; Brügger-Verdon, Valérie; Adam, Jacqueline; Ruthsatz, Tanja; Bain, Joseph; Schu, Daniel; Ventrici, Lisa; Edler, Monika; Lioe, Hadi; Patel, Kalpeshkumar; Chen, Chunsheng; Nguyen, Julia; Abdulla, Fuad; Zhang, Ping; Wassmer, Andreas; Jain, Meena; Mischnik, Marcel; Pelzing, Matthias; Martin, Kirstee; Davis, Roslyn; Didichenko, Svetlana; Schaub, Alexander; Brinkman, Nathan; Herzog, Eva; Zürcher, Adrian; Vercellotti, Gregory M; Kato, Gregory J; Höbarth, Gerald.
Afiliação
  • Gentinetta T; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Belcher JD; Division of Hematology, Oncology and Transplantation, Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Brügger-Verdon V; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Adam J; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Ruthsatz T; CSL Behring Innovation GmbH, 35041 Marburg, Germany.
  • Bain J; CSL Behring Innovation GmbH, 35041 Marburg, Germany.
  • Schu D; CSL Behring Innovation GmbH, 35041 Marburg, Germany.
  • Ventrici L; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Edler M; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Lioe H; Bio21 Institute, CSL Ltd., Parkville, VIC 3052, Australia.
  • Patel K; Bio21 Institute, CSL Ltd., Parkville, VIC 3052, Australia.
  • Chen C; Division of Hematology, Oncology and Transplantation, Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Nguyen J; Division of Hematology, Oncology and Transplantation, Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Abdulla F; Division of Hematology, Oncology and Transplantation, Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Zhang P; Division of Hematology, Oncology and Transplantation, Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Wassmer A; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Jain M; Research and Development, CSL Behring, King of Prussia, PA 19406, USA.
  • Mischnik M; CSL Behring Innovation GmbH, 35041 Marburg, Germany.
  • Pelzing M; Bio21 Institute, CSL Ltd., Parkville, VIC 3052, Australia.
  • Martin K; Bio21 Institute, CSL Ltd., Parkville, VIC 3052, Australia.
  • Davis R; Bio21 Institute, CSL Ltd., Parkville, VIC 3052, Australia.
  • Didichenko S; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Schaub A; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Brinkman N; Research and Development, CSL Behring Ltd., Kankakee, IL 60901, USA.
  • Herzog E; Research and Development, CSL Behring, King of Prussia, PA 19406, USA.
  • Zürcher A; Research and Development, CSL Behring AG, 3014 Bern, Switzerland.
  • Vercellotti GM; Division of Hematology, Oncology and Transplantation, Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Kato GJ; Research and Development, CSL Behring, King of Prussia, PA 19406, USA.
  • Höbarth G; CSL Behring GmbH, Walcherstraße 1A/Stiege 1, 1020 Vienna, Austria.
J Clin Med ; 11(3)2022 Jan 26.
Article em En | MEDLINE | ID: mdl-35160081
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article